标题
Trial Watch: Peptide-based anticancer vaccines
作者
关键词
-
出版物
OncoImmunology
Volume 4, Issue 4, Pages e974411
出版商
Informa UK Limited
发表日期
2015-01-09
DOI
10.4161/2162402x.2014.974411
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer Immunoediting from Immunosurveillance to Tumor Escape in Microvillus-Formed Niche: A Study of Syngeneic Orthotopic Rat Bladder Cancer Model in Comparison with Human Bladder Cancer
- (2015) Carl-Jørgen Arum et al. NEOPLASIA
- Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients
- (2014) E. A. Mittendorf et al. ANNALS OF ONCOLOGY
- Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine
- (2014) Yinin Hu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors
- (2014) Volker Lennerz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells
- (2014) Aaron P. Rapoport et al. CLINICAL CANCER RESEARCH
- New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
- (2014) Deepak Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- Feasibility study of personalized peptide vaccination for recurrent ovarian cancer patients
- (2014) Kouichiro Kawano et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer
- (2014) YOSHIE HIGASHIHARA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Antigen-Specific Immune Responses and Clinical Outcome After Vaccination With Glioma-Associated Antigen Peptides and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Children With Newly Diagnosed Malignant Brainstem and Nonbrainstem Gliomas
- (2014) Ian F. Pollack et al. JOURNAL OF CLINICAL ONCOLOGY
- Vaccination With NY-ESO-1 Overlapping Peptides Mixed With Picibanil OK-432 and Montanide ISA-51 in Patients With Cancers Expressing the NY-ESO-1 Antigen
- (2014) Hisashi Wada et al. JOURNAL OF IMMUNOTHERAPY
- Wilms Tumor Gene (WT1) Peptide–based Cancer Vaccine Combined With Gemcitabine for Patients With Advanced Pancreatic Cancer
- (2014) Sumiyuki Nishida et al. JOURNAL OF IMMUNOTHERAPY
- A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome
- (2014) Shoichi Hazama et al. Journal of Translational Medicine
- Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients
- (2014) Hisae Iinuma et al. Journal of Translational Medicine
- Phase I clinical trial of multiple-peptide vaccination for patients with advanced biliary tract cancer
- (2014) Atsushi Aruga et al. Journal of Translational Medicine
- The immunological and clinical effects of mutated ras peptide vaccine in combination with IL-2, GM-CSF, or both in patients with solid tumors
- (2014) Osama E Rahma et al. Journal of Translational Medicine
- Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
- (2014) Caroline Robert et al. LANCET
- Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
- (2014) Gary Middleton et al. LANCET ONCOLOGY
- A phase II trial evaluating the clinical and immunologic response of HLA-A2+ non-small cell lung cancer patients vaccinated with an hTERT cryptic peptide
- (2014) Athanasios Kotsakis et al. LUNG CANCER
- Structure-based programming of lymph-node targeting in molecular vaccines
- (2014) Haipeng Liu et al. NATURE
- A vaccine targeting mutant IDH1 induces antitumour immunity
- (2014) Theresa Schumacher et al. NATURE
- Insights into the initiation of TCR signaling
- (2014) Arup K Chakraborty et al. NATURE IMMUNOLOGY
- Intrinsic CD4+ T cell sensitivity and response to a pathogen are set and sustained by avidity for thymic and peripheral complexes of self peptide and MHC
- (2014) Stephen P Persaud et al. NATURE IMMUNOLOGY
- Therapeutic vaccines for cancer: an overview of clinical trials
- (2014) Ignacio Melero et al. Nature Reviews Clinical Oncology
- Specific active immunotherapy with a VEGF vaccine in patients with advanced solid tumors. Results of the CENTAURO antigen dose escalation phase I clinical trial
- (2014) J.V. Gavilondo et al. VACCINE
- Emerging Biological Treatments for Uterine Cervical Carcinoma
- (2014) Patrizia Vici et al. Journal of Cancer
- Carbohydrate-Mimetic Peptides for Pan Anti-Tumor Responses
- (2014) Thomas Kieber-Emmons et al. Frontiers in Immunology
- Receptor Pre-Clustering and T cell Responses: Insights into Molecular Mechanisms
- (2014) Mario Castro et al. Frontiers in Immunology
- Macrophages increase the resistance of pancreatic adenocarcinoma cells to gemcitabine by upregulating cytidine deaminase
- (2014) Moran Amit et al. OncoImmunology
- Trial Watch
- (2014) Fernando Aranda et al. OncoImmunology
- Novel immune checkpoint blocker approved for the treatment of advanced melanoma
- (2014) Lorenzo Galluzzi et al. OncoImmunology
- Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy
- (2014) Yuting Ma et al. OncoImmunology
- Trial Watch
- (2014) Erika Vacchelli et al. OncoImmunology
- A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodes
- (2014) Patrick M Dillon et al. Journal for ImmunoTherapy of Cancer
- Haptoglobin Proved a Prognostic Biomarker in Peripheral Blood of Patients with Personalized Peptide Vaccinations for Advanced Castration-Resistant Prostate Cancer
- (2013) Xiaoliang PANG et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Targeting dendritic cells--why bother?
- (2013) M. Kreutz et al. BLOOD
- A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time
- (2013) Masanori Noguchi et al. BMC CANCER
- Wilms’ Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses
- (2013) Benjamin Uttenthal et al. BRITISH JOURNAL OF HAEMATOLOGY
- AE37 peptide vaccination in prostate cancer: a 4-year immunological assessment updates on a phase I trial
- (2013) Sonia A. Perez et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study
- (2013) Peggy J. de Vos van Steenwijk et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy
- (2013) Yuting Ma et al. CANCER RESEARCH
- Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients
- (2013) Ryuji Takahashi et al. CANCER SCIENCE
- Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines
- (2013) D Hannani et al. CELL DEATH AND DIFFERENTIATION
- Biomarkers for Immunostimulatory Monoclonal Antibodies in Combination Strategies for Melanoma and Other Tumor Types
- (2013) P. A. Ascierto et al. CLINICAL CANCER RESEARCH
- Surveillance of the Tumor Mutanome by T Cells during Progression from Primary to Recurrent Ovarian Cancer
- (2013) Darin A. Wick et al. CLINICAL CANCER RESEARCH
- Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase
- (2013) T. Z. Iversen et al. CLINICAL CANCER RESEARCH
- Humoral immune responses to CTL epitope peptides from tumor-associated antigens are widely detectable in humans: A new biomarker for overall survival of patients with malignant diseases
- (2013) Satoko Matsueda et al. DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY
- Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients’ Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine
- (2013) Shigeru Yutani et al. Evidence-based Complementary and Alternative Medicine
- Prostate cancer vaccines
- (2013) Agnieszka Michael et al. Expert Review of Vaccines
- Phase I clinical trial of vaccination with LY6K-derived peptide in patients with advanced gastric cancer
- (2013) Hajime Ishikawa et al. Gastric Cancer
- Folate and folate receptor alpha antagonists mechanism of action in ovarian cancer
- (2013) Christen L. Walters et al. GYNECOLOGIC ONCOLOGY
- Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
- (2013) Laurence Zitvogel et al. IMMUNITY
- Heat-shock proteins as dendritic cell-targeting vaccines - getting warmer
- (2013) Shaun McNulty et al. IMMUNOLOGY
- Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican-3-derived peptide
- (2013) YOSHITAKA TADA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer
- (2013) Guru Sonpavde et al. INVESTIGATIONAL NEW DRUGS
- Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity
- (2013) Alexey Berezhnoy et al. JOURNAL OF CLINICAL INVESTIGATION
- Lung tumor NF-κB signaling promotes T cell–mediated immune surveillance
- (2013) Emily L. Hopewell et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety, Efficacy, and Biomarkers of Nivolumab With Vaccine in Ipilimumab-Refractory or -Naive Melanoma
- (2013) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- Decoding cell death signals in liver inflammation
- (2013) Catherine Brenner et al. JOURNAL OF HEPATOLOGY
- Targeting of Antigens to B Lymphocytes via CD19 as a Means for Tumor Vaccine Development
- (2013) Y. Ma et al. JOURNAL OF IMMUNOLOGY
- A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine For Patients With Advanced Pancreatic Cancer
- (2013) Nobuaki Suzuki et al. JOURNAL OF IMMUNOTHERAPY
- Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer
- (2013) Hiroyuki Suzuki et al. Journal of Translational Medicine
- HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
- (2013) Mariette I E van Poelgeest et al. Journal of Translational Medicine
- Phase I/II clinical trial using HLA-A24-restricted peptide vaccine derived from KIF20A for patients with advanced pancreatic cancer
- (2013) Shingo Asahara et al. Journal of Translational Medicine
- Immunological checkpoint inhibitors enter adolescence
- (2013) Anna K Nowak LANCET ONCOLOGY
- Reply to ‘Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance’
- (2013) Hee Jin Lee et al. MODERN PATHOLOGY
- Drug development: Releasing the brakes
- (2013) Karen Weintraub NATURE
- Metabolic targets for cancer therapy
- (2013) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Combination Checkpoint Blockade — Taking Melanoma Immunotherapy to the Next Level
- (2013) James L. Riley NEW ENGLAND JOURNAL OF MEDICINE
- Synthesized Multiple Antigenic Polypeptide Vaccine Based on B-Cell Epitopes of Human Heparanase Could Elicit a Potent Antimetastatic Effect on Human Hepatocellular Carcinoma In Vivo
- (2013) Jun Zhang et al. PLoS One
- Alloreactive cytotoxic T cells provide means to decipher the immunopeptidome and reveal a plethora of tumor-associated self-epitopes
- (2013) S. Kumari et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TERT Promoter Mutations in Familial and Sporadic Melanoma
- (2013) S. Horn et al. SCIENCE
- Highly Recurrent TERT Promoter Mutations in Human Melanoma
- (2013) F. W. Huang et al. SCIENCE
- Immune Checkpoint Blockade: The Hope for Immunotherapy as a Treatment of Lung Cancer?
- (2013) Julie R. Brahmer SEMINARS IN ONCOLOGY
- Immunosurveillance as a regulator of tissue homeostasis
- (2013) Laura Senovilla et al. TRENDS IN IMMUNOLOGY
- Frequency of TERT promoter mutations in human cancers
- (2013) João Vinagre et al. Nature Communications
- Maintenance of complete remission after allogeneic stem cell transplantation in leukemia patients treated with Wilms tumor 1 peptide vaccine
- (2013) T Maeda et al. Blood Cancer Journal
- Significant clinical response of progressive recurrent ovarian clear cell carcinoma to glypican-3-derived peptide vaccine therapy
- (2013) Shiro Suzuki et al. Human Vaccines & Immunotherapeutics
- Overcoming Antigenic Diversity by Enhancing the Immunogenicity of Conserved Epitopes on the Malaria Vaccine Candidate Apical Membrane Antigen-1
- (2013) Sheetij Dutta et al. PLoS Pathogens
- Boosting anticancer vaccines
- (2013) Alessia Ricupito et al. OncoImmunology
- The role of FOXP3 in disease progression in colorectal cancer patients
- (2013) Tanja Grimmig et al. OncoImmunology
- Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment
- (2013) Michael H Kershaw et al. OncoImmunology
- Is there a future for adoptive cell transfer in melanoma patients?
- (2013) Michal J. Besser OncoImmunology
- Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patients
- (2013) Trine Zeeberg Iversen et al. OncoImmunology
- Immune correlates of melanoma survival in adoptive cell therapy
- (2013) Agnes Fermin Lee et al. OncoImmunology
- Current trends of anticancer immunochemotherapy
- (2013) Erika Vacchelli et al. OncoImmunology
- Approaching untargetable tumor-associated antigens with antibodies
- (2013) Tao Dao et al. OncoImmunology
- Replenish the source within
- (2013) Jaikumar Duraiswamy et al. OncoImmunology
- Immunotherapy of HPV-associated head and neck cancer
- (2013) Mevyn Nizard et al. OncoImmunology
- Role of non-classical MHC class I molecules in cancer immunosuppression
- (2013) Grazyna Kochan et al. OncoImmunology
- Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients
- (2013) Ryuji Okuyama et al. OncoImmunology
- Myeloid derived suppressor cells
- (2013) Todd J. Waldron et al. OncoImmunology
- Blockade of the PD-1 pathway enhances the efficacy of adoptive cell therapy against cancer
- (2013) Weiyi Peng et al. OncoImmunology
- Role of dendritic cells in the regulation of antitumor immunity
- (2013) Nathalie Wathelet et al. OncoImmunology
- Peptide-based anticancer vaccines
- (2013) Yared Hailemichael et al. OncoImmunology
- Biological insights into BRAFV600mutations in melanoma patient
- (2013) Giuseppina Improta et al. OncoImmunology
- A new role for NFκB in immunosurveillance and its implications for cancer immunotherapy
- (2013) Amer A Beg et al. OncoImmunology
- Antitumor activity of an immunocytokine composed of an anti-GD2 antibody and the IL-15 superagonist RLI
- (2013) Marie Vincent et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Victories and deceptions in tumor immunology
- (2013) Guido Kroemer et al. OncoImmunology
- Personalized medicine for cancer therapy
- (2013) Christina Springstead Scanlon et al. OncoImmunology
- A role for CCL2 in both tumor progression and immunosurveillance
- (2013) Ming Li et al. OncoImmunology
- Cancer vaccines
- (2013) Kavitha Yaddanapudi et al. OncoImmunology
- Vemurafenib enhances MHC induction inBRAFV600Ehomozygous melanoma cells
- (2013) Bishu Sapkota et al. OncoImmunology
- Blockade of PD-1 immunosuppression boosts CAR T-cell therapy
- (2013) Liza B John et al. OncoImmunology
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan
- (2013) Shakeel Modak et al. OncoImmunology
- The TLR7 agonist imiquimod as an adjuvant for radiotherapy-elicited in situ vaccination against breast cancer
- (2013) Sandra Demaria et al. OncoImmunology
- Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer
- (2013) Ben C. Creelan et al. OncoImmunology
- BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes
- (2013) Zachary A Cooper et al. OncoImmunology
- Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumors
- (2013) Willem W Overwijk et al. Journal for ImmunoTherapy of Cancer
- A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma
- (2013) Daniel M Geynisman et al. Journal for ImmunoTherapy of Cancer
- Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy
- (2012) Daisuke Nobuoka et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion
- (2012) M. Platten et al. CANCER RESEARCH
- Exploiting the Mutanome for Tumor Vaccination
- (2012) J. C. Castle et al. CANCER RESEARCH
- Limited Induction of Tumor Cross-Reactive T Cells without a Measurable Clinical Benefit in Early Melanoma Patients Vaccinated with Human Leukocyte Antigen Class I-Modified Peptides
- (2012) P. Filipazzi et al. CLINICAL CANCER RESEARCH
- Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients
- (2012) P. Sabbatini et al. CLINICAL CANCER RESEARCH
- Heat Shock Proteins (HSPs) Based Anti-Cancer Vaccines
- (2012) D.R. Ciocca et al. CURRENT MOLECULAR MEDICINE
- Resiquimod, a topical drug for viral skin lesions and skin cancer
- (2012) Thomas Meyer et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Antigen loss and tumor-mediated immunosuppression facilitate tumor recurrence
- (2012) Brian M Olson et al. Expert Review of Vaccines
- Chemotherapy for advanced and recurrent cervical carcinoma: Results from cooperative group trials
- (2012) Charles A. Leath et al. GYNECOLOGIC ONCOLOGY
- Induction of CD8 T-cell responses restricted to multiple HLA class I alleles in a cancer patient by immunization with a 20-mer NY-ESO-1f (NY-ESO-1 91-110) peptide
- (2012) Shingo Eikawa et al. INTERNATIONAL JOURNAL OF CANCER
- Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens
- (2012) Koji Kono et al. Journal of Translational Medicine
- Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance
- (2012) Hyesil Seol et al. MODERN PATHOLOGY
- Expression of tumour-specific antigens underlies cancer immunoediting
- (2012) Michel DuPage et al. NATURE
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Mitochondria: master regulators of danger signalling
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
- (2012) Jeffrey A. Sosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Pilot Study of IL-2Rα Blockade during Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with Glioblastoma
- (2012) John H. Sampson et al. PLoS One
- Humoral Immune Responses to a Single Allele PfAMA1 Vaccine in Healthy Malaria-Naïve Adults
- (2012) Edmond J. Remarque et al. PLoS One
- An Immunosurveillance Mechanism Controls Cancer Cell Ploidy
- (2012) L. Senovilla et al. SCIENCE
- Intradermally administered TLR4 agonist GLA-SE enhances the capacity of human skin DCs to activate T cells and promotes emigration of Langerhans cells
- (2012) Laura P. Schneider et al. VACCINE
- The Role of Heat Shock Proteins in Antigen Cross Presentation
- (2012) Ayesha Murshid et al. Frontiers in Immunology
- High-quality and high-avidity T cell clones specific for tumor-associated antigens and how to find them
- (2012) Susanne Wilde et al. OncoImmunology
- Targeting the right regulatory T-cell population for tumor immunotherapy
- (2012) Vivian L. Weiss et al. OncoImmunology
- Sound efficacy of prophylactic HPV vaccination
- (2012) Matti Lehtinen et al. OncoImmunology
- Combination of vaccine and immune checkpoint inhibitor is safe with encouraging clinical activity
- (2012) Ravi A Madan et al. OncoImmunology
- Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer
- (2012) Helene Pere et al. OncoImmunology
- Survivin the battle against immunosuppression
- (2012) Edwin R. Manuel et al. OncoImmunology
- Melanoma immunoediting by NK cells
- (2012) Mirna Balsamo et al. OncoImmunology
- Targeting the tumor mutanome for personalized vaccination therapy
- (2012) Sebastian Kreiter et al. OncoImmunology
- Radiation and immunotherapy
- (2012) Steven K. Seung et al. OncoImmunology
- Human dendritic cells adenovirally-engineered to express three defined tumor antigens promote broad adaptive and innate immunity
- (2012) LeeAnn T. Blalock et al. OncoImmunology
- NY-ESO-1 expression in sarcomas
- (2012) Jin-Ping Lai et al. OncoImmunology
- Trial Watch: Monoclonal antibodies in cancer therapy
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001
- (2012) Else-Marit Inderberg-Suso et al. OncoImmunology
- Trial watch
- (2012) Laura Senovilla et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Predicting the efficacy of cancer vaccines by evaluating T-cell responses
- (2012) Suzanne van Duikeren et al. OncoImmunology
- Epitope spreading contributes to effective immunotherapy in metastatic melanoma patients
- (2011) Nicola Hardwick et al. Immunotherapy
- GLA-SE, a Synthetic Toll-like Receptor 4 Agonist, Enhances T-Cell Responses to Influenza Vaccine in Older Adults
- (2011) Hayedeh Behzad et al. JOURNAL OF INFECTIOUS DISEASES
- The Human Immunopeptidome Project, a Suggestion for yet another Postgenome Next Big Thing
- (2011) Arie Admon et al. MOLECULAR & CELLULAR PROTEOMICS
- The biology of cancer testis antigens: Putative function, regulation and therapeutic potential
- (2011) Elisabetta Fratta et al. Molecular Oncology
- The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation
- (2011) E. Caron et al. Molecular Systems Biology
- Ipilimumab
- (2011) Vernon K. Sondak et al. NATURE REVIEWS DRUG DISCOVERY
- Mitotic catastrophe: a mechanism for avoiding genomic instability
- (2011) Ilio Vitale et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
- (2011) Douglas J. Schwartzentruber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Ipilimumab: A novel immunostimulatory monoclonal antibody for the treatment of cancer
- (2011) Grazia Graziani et al. PHARMACOLOGICAL RESEARCH
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Contributions of humoral and cellular immunity to vaccine-induced protection in humans
- (2011) Ian J. Amanna et al. VIROLOGY
- Carbohydrate Mimetic Peptides Augment Carbohydrate-Reactive Immune Responses in the Absence of Immune Pathology
- (2011) Leah Hennings et al. Cancers
- Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity
- (2010) X. Liu et al. BLOOD
- LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling
- (2010) R Matsuda et al. BRITISH JOURNAL OF CANCER
- Illicit survival of cancer cells during polyploidization and depolyploidization
- (2010) I Vitale et al. CELL DEATH AND DIFFERENTIATION
- The status of platinum anticancer drugs in the clinic and in clinical trials
- (2010) Nial J. Wheate et al. DALTON TRANSACTIONS
- Immunity unleashed in melanoma
- (2010) Michael K Erdmann LANCET ONCOLOGY
- Hydroxyamidine Inhibitors of Indoleamine-2,3-dioxygenase Potently Suppress Systemic Tryptophan Catabolism and the Growth of IDO-Expressing Tumors
- (2010) H. K. Koblish et al. MOLECULAR CANCER THERAPEUTICS
- Ipilimumab success in melanoma provides boost for cancer immunotherapy
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Genomic instability — an evolving hallmark of cancer
- (2010) Simona Negrini et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines
- (2010) Rhea N. Coler et al. PLoS One
- A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosis
- (2010) S. Bertholet et al. Science Translational Medicine
- Immunogenic cell death, DAMPs and anticancer therapeutics: An emerging amalgamation
- (2009) Abhishek D. Garg et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
- (2009) X. Liu et al. CURRENT CANCER DRUG TARGETS
- The antiviral activity of toll-like receptor 7 and 7/8 agonists
- (2009) R.L. Miller et al. DRUG NEWS & PERSPECTIVES
- The Lewis-Y Carbohydrate Antigen is Expressed by Many Human Tumors and Can Serve as a Target for Genetically Redirected T cells Despite the Presence of Soluble Antigen in Serum
- (2009) Jennifer A. Westwood et al. JOURNAL OF IMMUNOTHERAPY
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
- (2009) Jedd D Wolchok et al. LANCET ONCOLOGY
- Immune Therapy for Cancer
- (2008) Michael Dougan et al. Annual Review of Immunology
- Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation
- (2008) Ayesha Murshid et al. Expert Review of Vaccines
- Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer
- (2008) Tetsuhiro Tsuruma et al. Journal of Translational Medicine
- TLR7 and TLR8 as targets in cancer therapy
- (2008) M P Schön et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started